Attendance
|
Category
|
Names
|
|
Assembly Members:
|
Dai Lloyd AM (Chair)
Jayne Bryant AM
Rhun ap Iorwerth AM
Caroline Jones AM
Julie Morgan AM
Lynne Neagle AM
|
|
Witnesses:
|
Sarah Rochira, Older People’s
Commissioner for Wales
Sue Phelps, Alzheimer's Society
Professor Sue Jordan, Swansea University
Tim Banner, Cardiff and Vale University Health
Board
Suzanne Tarrant
|
|
Committee Staff:
|
Sian Thomas (Clerk)
Sarah Sargent (Deputy Clerk)
Amy Clifton (Researcher)
Dr Paul Worthington (Researcher)
|
<AI1>
1
Introductions, apologies, substitutions
and declarations of interest
1.1
The Chair welcomed Members to the meeting.
1.2
Apologies were received from Angela Burns AM and Dawn Bowden
AM.
</AI1>
<AI2>
2
Use of antipsychotic medication in care
homes - evidence session 1 - Older People's Commissioner for
Wales
2.1 The Committee received evidence from the
Older People’s Commissioner for Wales.
</AI2>
<AI3>
3
Use of antipsychotic medication in care
homes - evidence session 2 - Alzheimer's Society Cymru
3.1 The Committee received evidence from Sue
Phelps of Alzheimer’s Society Cymru.
</AI3>
<AI4>
4
Use of antipsychotic medication in care
homes - evidence session 3 - Professor Sue Jordan
4.1 The Committee received evidence from
Professor Sue Jordan and Tim Banner.
</AI4>
<AI5>
5
Use of antipsychotic medication in care
homes - evidence session 4 - people affected by the use of
antipsychotic medication in care homes
5.1 The Committee received evidence from
Suzanne Tarrant.
</AI5>
<AI6>
6
Paper(s) to note
</AI6>
<AI7>
6.1
Letter from the Royal College of
Psychiatrists following 15 June meeting
6.1a The Committee noted the letter from the
Royal College of Psychiatrists in relation to the inquiry into
loneliness and isolation.
</AI7>
<AI8>
6.2
Letter from the Chair of the Public
Accounts Committee regarding Governance Arrangements at Betsi
Cadwaladr University Health Board
6.2a The Committee noted the letter from the
Chair of the Public Accounts Committee.
</AI8>
<AI9>
6.3
Scrutiny of the Welsh Government Budget
2017-18 - in year financial scrutiny - letter from the Cabinet
Secretary and Minister following 29 June meeting
6.3a The Committee noted the letter from the
Cabinet Secretary and Minister.
</AI9>
<AI10>
6.4
Letter from the Royal College of General
Practitioners following the report launch
6.4a The Committee noted the letter from the
Royal College of General Practitioners in relation to the launch of
the Committee’s report on medical recruitment.
</AI10>
<AI11>
6.5
Letter from the Chair of the Finance
Committee regarding the Welsh Government draft budget
2018-19
6.5a The Committee noted the letter from the
Chair of the Finance Committee.
</AI11>
<AI12>
6.6
Letter from the Chair of the Children,
Young People and Education Committee regarding the Welsh Government
draft budget 2018-19
6.6a The Committee noted the letter from the
Chair of the Children, Young People and Education Committee.
</AI12>
<AI13>
6.7
Letter from the House of Commons Health
Committee
6.7a The Committee noted the letter from the
House of Commons Health Committee.
</AI13>
<AI14>
6.8
Letter from the Minister for Social
Services and Public Health regarding commencement of sections 2 and
3 (obesity)
6.8a The Committee noted the letter from the
Minister for Social Services and Public Health in relation to the
Public Health (Wales) Act 2017.
</AI14>
<AI15>
6.9
Letter from the Cabinet Secretary for
Health, Well-being and Sport regarding guidance supporting the
implementation of the Act
6.9a The Committee noted the letter from the
Cabinet Secretary for Health, Well-being and Sport in relation to
the Nurse Staffing levels (Wales) Act 2016.
</AI15>
<AI16>
7
Motion under Standing Order 17.42 to
resolve to exclude the public from the remainder of the
meeting
7.1 The Committee agreed the motion.
</AI16>
<AI17>
8
Use of antipsychotic medication in care
homes - evidence session 5 - people affected by the use of
antipsychotic medication in care homes
8.1 The Committee heard from a person who has
had direct experience of the use of anti-psychotic medication in
care homes and hospital settings.
</AI17>
<AI18>
9
Use of anti-psychotic medication in care
homes - consideration of evidence
9.1 The Committee considered the evidence
given during items 2 3, 4, 5 and 8 of the meeting.
</AI18>
<AI19>
10 Inquiry into primary care - consideration of draft
report
10.1 The Committee considered a first draft of
the report of its inquiry into primary care clusters.
</AI19>
<TRAILER_SECTION>
</TRAILER_SECTION>
<LAYOUT_SECTION>
1.FIELD_TITLE
FIELD_SUMMARY
</LAYOUT_SECTION>
<TITLE_ONLY_LAYOUT_SECTION>
2.FIELD_TITLE
</TITLE_ONLY_LAYOUT_SECTION>
<HEADING_LAYOUT_SECTION></HEADING_LAYOUT_SECTION>
<TITLED_COMMENT_LAYOUT_SECTION>
FIELD_TITLE
FIELD_SUMMARY
</TITLED_COMMENT_LAYOUT_SECTION>
<COMMENT_LAYOUT_SECTION>
FIELD_SUMMARY
</COMMENT_LAYOUT_SECTION>
<SUBNUMBER_LAYOUT_SECTION>
2.1FIELD_TITLE
FIELD_SUMMARY
</SUBNUMBER_LAYOUT_SECTION>
<TITLE_ONLY_SUBNUMBER_LAYOUT_SECTION>
2.2FIELD_TITLE
</TITLE_ONLY_SUBNUMBER_LAYOUT_SECTION>